2-(4-hydroxypiperidino)-1-alkanol derivatives as antiischemic agents
申请人:Pfizer Inc.
公开号:US06255322B1
公开(公告)日:2001-07-03
A series of 2-(4-hydroxypiperidino)-1-alkanol derivatives are useful as medicaments for the treatment of traumatic injuries to the brain and spinal cord and neuronal degenerative diseases including senile dementias, in mammals, especially humans.